☆ 4.8 Article

Glycoprotein B Antibodies Completely Neutralize EBV Infection of B Cells

FRONTIERS IN IMMUNOLOGY (2022)

相关参考文献

注意：仅列出部分参考文献，下载原文获取全部文献信息。

Review Oncology

Estimating the global burden of Epstein-Barr virus-related cancers

Yide Wong et al.

Summary: More than 90% of the adult population globally is chronically infected by the Epstein-Barr virus (EBV), which is associated with various malignancies. This review focuses on six cancers with a relatively large EBV-related case burden and estimates the new cases and deaths in 2020. The findings highlight the significant global impact of EBV-related cancers and suggest potential for EBV-specific therapeutic interventions.

JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY (2022)

添加到收藏夹

Editorial Material Pharmacology & Pharmacy

Longitudinal Analysis Suggests Epstein--Barr as Cause of Multiple Sclerosis

[Anonymous]

CLINICAL PHARMACOLOGY & THERAPEUTICS (2022)

添加到收藏夹

Review Virology

Recent progress in development of monoclonal antibodies against human cytomegalovirus

Xiaohua Ye et al.

Summary: This article discusses the impact and treatment methods of human cytomegalovirus, focusing on the potential use of monoclonal antibodies and the progress in clinical evaluation.

CURRENT OPINION IN VIROLOGY (2022)

添加到收藏夹

Article Virology

A Neutralizing Antibody Targeting gH Provides Potent Protection against EBV Challenge In Vivo

Junping Hong et al.

Summary: This study identified an antibody that can neutralize Epstein-Barr virus (EBV) and protect mice from fatal EBV infection. The antibody targets an important epitope on the viral protein gH/gL, which is critical for viral attachment and fusion with epithelial cells. This research has important implications for the prevention of EBV-induced diseases and the design of vaccines.

JOURNAL OF VIROLOGY (2022)

添加到收藏夹

Article Multidisciplinary Sciences

Longitudinal analysis reveals high prevalence of Epstein-Barr virus associated with multiple sclerosis

Kjetil Bjornevik et al.

Summary: This study suggests that multiple sclerosis may be caused by Epstein-Barr virus, with no direct association with other viral infections. These findings provide clues to the primary cause of MS.

SCIENCE (2022)

添加到收藏夹

Review Microbiology

The structural basis of herpesvirus entry

Sarah A. Connolly et al.

Summary: Herpesviruses are enveloped, double-stranded DNA viruses that establish lifelong infections and cause a variety of diseases. The entry into host cells involves the binding of the virus to specific receptors and the coordinated action of multiple viral entry glycoproteins. While the core fusion machinery is conserved among all herpesviruses, each species uses distinct receptors and receptor-binding glycoproteins.

NATURE REVIEWS MICROBIOLOGY (2021)

添加到收藏夹

Article Microbiology

The N-terminus of varicella-zoster virus glycoprotein B has a functional role in fusion

Stefan L. Oliver et al.

Summary: The Varicella-zoster virus (VZV) is an important alphaherpesvirus responsible for various skin infections. The fusion process of the virus involves glycoproteins gB, gH, and gL, with the N-terminus of gB playing a critical role. The interaction of neutralizing and non-neutralizing antibodies with gB reveals important insights into the fusion mechanism, with mutations affecting the N-terminus of gB significantly inhibiting viral propagation.

PLOS PATHOGENS (2021)

添加到收藏夹

Article Virology

Dose-Dependent Outcome of EBV Infection of Humanized Mice Based on Green Raji Unit (GRU) Doses

Haiwen Chen et al.

Summary: Humanized mouse models are used for studying EBV infection. Inoculation with low and high doses of Akata-EBV-GFP in vivo leads to infection and lymphoma models respectively. Low doses result in latent infection, while high doses cause B cell death and lymphoma formation.

VIRUSES-BASEL (2021)

添加到收藏夹

Article Virology

Antibody Generation and Immunogenicity Analysis of EBV gp42 N-Terminal Region

Junping Hong et al.

Summary: This study successfully generated nine monoclonal antibodies against the EBV gp42 N-terminal region, providing useful tools for investigating viral infection mechanisms and evaluating the immunogenicity of the gp42 N-terminal region. Additionally, the research showed that some antibodies have significant binding capacity to different binding regions of the gp42 protein.

VIRUSES-BASEL (2021)

添加到收藏夹

Article Multidisciplinary Sciences

A potent and protective human neutralizing antibody targeting a novel vulnerable site of Epstein-Barr virus

Qian-Ying Zhu et al.

Summary: Researchers have isolated an EBV-specific antibody 1D8, which effectively neutralizes EBV infection in B cells and epithelial cells, and reduces tumor burden in humanized mice by interfering with gH/gL-mediated membrane fusion and binding.

NATURE COMMUNICATIONS (2021)

添加到收藏夹

Article Immunology

Immunization with Epstein-Barr Virus Core Fusion Machinery Envelope Proteins Elicit High Titers of Neutralizing Activities and Protect Humanized Mice from Lethal Dose EBV Challenge

Xinle Cui et al.

Summary: EBV core fusion machinery proteins can induce high titer EBV neutralizing antibodies for both B lymphocytes and epithelial cells, with a synergistic effect when gH/gL is combined with trimeric gB. The sera from immunized rabbits not only protect humanized mice from lethal EBV challenge, but also significantly reduce EBV load in peripheral blood. These findings suggest that the combination of gH/gL and trimeric gB could be a promising prophylactic EBV vaccine.

VACCINES (2021)

添加到收藏夹

Review Immunology

The Status and Prospects of Epstein-Barr Virus Prophylactic Vaccine Development

Cong Sun et al.

Summary: EBV is a common human herpesvirus associated with infectious mononucleosis, malignancies, and autoimmune diseases. Despite efforts to develop a prophylactic vaccine, there is currently no EBV vaccine in clinical use. Insights from the COVID-19 pandemic and global vaccine development offer opportunities for designing an effective prophylactic EBV vaccine to control worldwide EBV infection and associated diseases.

FRONTIERS IN IMMUNOLOGY (2021)

添加到收藏夹

Review Immunology

Development of a Vaccine against Human Cytomegalovirus: Advances, Barriers, and Implications for the Clinical Practice

Sara Scarpini et al.

Summary: hCMV is a common cause of congenital infection, leading to potential permanent impairment and severe disease in immunocompromised individuals. Research on hCMV vaccines is ongoing, but challenges in development include the virus's ability to evade immune response and identifying target populations for vaccination.

VACCINES (2021)

添加到收藏夹

Article Cell Biology

Neutralizing antibodies against Epstein-Barr virus infection of B cells can protect from oral viral challenge in the rhesus macaque animal model

Janine Muhe et al.

Summary: The study found that high-titer B cell-neutralizing antibodies alone can provide complete protection of rhesus macaques from oral LCV challenge, highlighting their importance as targets for EBV vaccine development.

CELL REPORTS MEDICINE (2021)

添加到收藏夹

Review Biochemistry & Molecular Biology

Targeting the signaling in Epstein-Barr virus-associated diseases: mechanism, regulation, and clinical study

Ya Cao et al.

Summary: Epstein-Barr virus-associated diseases are significant global health concerns, responsible for a portion of human malignancies and non-neoplastic diseases. Recent research findings on EBV involve DNA methylation, metabolic changes, oxidative stress, RNA variations, and potential therapeutic strategies.

SIGNAL TRANSDUCTION AND TARGETED THERAPY (2021)

添加到收藏夹

Article Immunology

The Status of Vaccine Development Against the Human Cytomegalovirus

Stanley A. Plotkin et al.

JOURNAL OF INFECTIOUS DISEASES (2020)

添加到收藏夹

Article Immunology

A Pentavalent Epstein-Barr Virus-Like Particle Vaccine Elicits High Titers of Neutralizing Antibodies against Epstein-Barr Virus Infection in Immunized Rabbits

Gabriela M. Escalante et al.

VACCINES (2020)

添加到收藏夹

Review Microbiology

Recent Advances in Diagnostic Approaches for Epstein-Barr Virus

Mai Abdel Haleem Abusalah et al.

PATHOGENS (2020)

添加到收藏夹

Article Microbiology

Recognition of a highly conserved glycoprotein B epitope by a bivalent antibody neutralizing HCMV at a post-attachment step

Xiaohua Ye et al.

PLOS PATHOGENS (2020)

添加到收藏夹

Article Multidisciplinary Sciences

A glycoprotein B-neutralizing antibody structure at 2.8 Å uncovers a critical domain for herpesvirus fusion initiation

Stefan L. Oliver et al.

NATURE COMMUNICATIONS (2020)

添加到收藏夹

Article Multidisciplinary Sciences

Molecular basis of EphA2 recognition by gHgL from gammaherpesviruses

Chao Su et al.

NATURE COMMUNICATIONS (2020)

添加到收藏夹

Article Cell Biology

Neutralizing Antibodies Protect against Oral Transmission of Lymphocryptovirus

Swati Singh et al.

CELL REPORTS MEDICINE (2020)

添加到收藏夹

Article Immunology

Immunization with Components of the Viral Fusion Apparatus Elicits Antibodies That Neutralize Epstein-Barr Virus in B Cells and Epithelial Cells

Wei Bu et al.

IMMUNITY (2019)

添加到收藏夹

Review Oncology

The Global Landscape of EBV-Associated Tumors

Claire Shannon-Lowe et al.

FRONTIERS IN ONCOLOGY (2019)

添加到收藏夹

Review Microbiology

Epithelial cell infection by Epstein-Barr virus

Jia Chen et al.

FEMS MICROBIOLOGY REVIEWS (2019)

添加到收藏夹

Article Immunology

An Antibody Targeting the Fusion Machinery Neutralizes Dual-Tropic Infection and Defines a Site of Vulnerability on Epstein-Barr Virus

Joost Snijder et al.

IMMUNITY (2018)

添加到收藏夹

Review Virology

Primary Epstein-Barr virus infection

Samantha K. Dunmire et al.

JOURNAL OF CLINICAL VIROLOGY (2018)

添加到收藏夹

Article Microbiology

Epstein-Barr virus activates F-box protein FBXO2 to limit viral infectivity by targeting glycoprotein B for degradation

Hao-Jiong Zhang et al.

PLOS PATHOGENS (2018)

添加到收藏夹

Article Microbiology

Different functional states of fusion protein gB revealed on human cytomegalovirus by cryo electron tomography with Volta phase plate

Zhu Si et al.

PLOS PATHOGENS (2018)

添加到收藏夹

Review Biochemistry & Molecular Biology

Global aspects of viral glycosylation

Ieva Bagdonaite et al.

GLYCOBIOLOGY (2018)

添加到收藏夹

Review Biology

Epstein-Barr virus infection and nasopharyngeal carcinoma

Sai Wah Tsao et al.

PHILOSOPHICAL TRANSACTIONS OF THE ROYAL SOCIETY B-BIOLOGICAL SCIENCES (2017)

添加到收藏夹

Review Biochemistry & Molecular Biology

Structural and Mechanistic Insights into the Tropism of Epstein-Barr Virus

Britta S. Moehl et al.

MOLECULES AND CELLS (2016)

添加到收藏夹

Article Multidisciplinary Sciences

Two distinct trimeric conformations of natively membrane-anchored full-length herpes simplex virus 1 glycoprotein B

Tzviya Zeev-Ben-Mordehai et al.

PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2016)

添加到收藏夹

Article Microbiology

The Epstein-Barr Virus Glycoprotein gp150 Forms an Immune-Evasive Glycan Shield at the Surface of Infected Cells

Anna M. Gram et al.

PLOS PATHOGENS (2016)

添加到收藏夹

Review Oncology

Epstein-Barr virus: more than 50 years old and still providing surprises

Lawrence S. Young et al.

NATURE REVIEWS CANCER (2016)

添加到收藏夹

Article Biochemistry & Molecular Biology

Recent mechanistic and structural insights on class III viral fusion glycoproteins

Eduard Baquero et al.

CURRENT OPINION IN STRUCTURAL BIOLOGY (2015)

添加到收藏夹

Review Virology

EBV glycoproteins: where are we now?

Lindsey M. Hutt-Fletcher

FUTURE VIROLOGY (2015)

添加到收藏夹

Article Multidisciplinary Sciences

Cryo-EM structures elucidate neutralizing mechanisms of anti-chikungunya human monoclonal antibodies with therapeutic activity

Feng Long et al.

PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2015)

添加到收藏夹

Article Immunology

Identification of the critical attribute(s) of EBV gp350 antigen required for elicitation of a neutralizing antibody response in vivo

Esteban Servat et al.

VACCINE (2015)

添加到收藏夹

Article Virology

Contribution of N-linked glycans on HSV-2 gB to cell-cell fusion and viral entry

Sukun Luo et al.

VIROLOGY (2015)

添加到收藏夹

Review Virology

Herpesvirus gB: A Finely Tuned Fusion Machine

Rebecca S. Cooper et al.

VIRUSES-BASEL (2015)

添加到收藏夹

Article Multidisciplinary Sciences

Neuropilin 1 is an entry factor that promotes EBV infection of nasopharyngeal epithelial cells

Hong-Bo Wang et al.

NATURE COMMUNICATIONS (2015)

添加到收藏夹

Article Multidisciplinary Sciences

Structure of HCMV glycoprotein B in the postfusion conformation bound to a neutralizing human antibody

Sumana Chandramouli et al.

NATURE COMMUNICATIONS (2015)

添加到收藏夹

Review Oncology

The Epstein-Barr virus and the pathogenesis of lymphoma

Martina Vockerodt et al.

JOURNAL OF PATHOLOGY (2015)

添加到收藏夹

Review Oncology

The role of Epstein-Barr virus in epithelial malignancies

Sai-Wah Tsao et al.

JOURNAL OF PATHOLOGY (2015)

添加到收藏夹

News Item Biochemistry & Molecular Biology

The cancer-virus cures

David Holmes

NATURE MEDICINE (2014)

添加到收藏夹

Review Oncology

Epstein-Barr virus infection mechanisms

Liudmila S. Chesnokova et al.

CHINESE JOURNAL OF CANCER (2014)

添加到收藏夹

Article Virology

Nonhuman primate models for Epstein-Barr virus infection

Fred Wang

CURRENT OPINION IN VIROLOGY (2013)

添加到收藏夹

Review Microbiology

Fusing structure and function: a structural view of the herpesvirus entry machinery

Sarah A. Connolly et al.

NATURE REVIEWS MICROBIOLOGY (2011)

添加到收藏夹

Editorial Material Cell Biology

Epstein-Barr Virus: An Important Vaccine Target for Cancer Prevention

Jeffrey I. Cohen et al.

SCIENCE TRANSLATIONAL MEDICINE (2011)

添加到收藏夹

Article Microbiology

Soluble Rhesus Lymphocryptovirus gp350 Protects against Infection and Reduces Viral Loads in Animals that Become Infected with Virus after Challenge

Junji Sashihara et al.

PLOS PATHOGENS (2011)

添加到收藏夹

Article Multidisciplinary Sciences

Structure of a trimeric variant of the Epstein-Barr virus glycoprotein B

Marija Backovic et al.

PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2009)

添加到收藏夹

Article Virology

EBV BMRF-2 facilitates cell-to-cell spread of virus within polarized oral epithelial cells

Jianqiao Xiao et al.

VIROLOGY (2009)

添加到收藏夹

Article Virology

Human antibody titers to Epstein-Barr Virus (EBV) gp350 correlate with neutralization of infectivity better than antibody titers to EBV gp42 using a rapid flow cytometry-based EBV neutralization assay

Junji Sashihara et al.

VIROLOGY (2009)

添加到收藏夹

Article Virology

Characterization of EBV gB indicates properties of both class I and class II viral fusion proteins

Marija Backovic et al.

VIROLOGY (2007)

添加到收藏夹

Article Biochemistry & Molecular Biology

Structure of the Epstein-Barr virus major envelope glycoprotein

Gerda Szakonyi et al.

NATURE STRUCTURAL & MOLECULAR BIOLOGY (2006)

添加到收藏夹

Article Multidisciplinary Sciences

Glycoprotein gp110 of Epstein-Barr virus determines viral tropism and efficiency of infection

B Neuhierl et al.

PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2002)

添加到收藏夹

© Peeref 2019-2024. All rights reserved.